주식회사 나노백스

{
  "address": "제주 제주시",
  "ceo_name": "김봉윤",
  "certificate": [
    {
      "cert_number": "20180102027",
      "changes": "",
      "disclosure_date": "2018-03-05",
      "first_cert_date": "2018-03-05",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-03-05 ~ 2020-03-04"
    },
    {
      "cert_number": "20200103139",
      "changes": "",
      "disclosure_date": "2020-03-18",
      "first_cert_date": "2018-03-05",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-03-05 ~ 2022-03-04"
    },
    {
      "cert_number": "20220406010040",
      "changes": "",
      "disclosure_date": "2022-04-06",
      "first_cert_date": "2018-03-05",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2022-03-05 ~ 2025-03-04"
    },
    {
      "cert_number": "20250226010016",
      "changes": "기업명",
      "disclosure_date": "2025-02-26",
      "first_cert_date": "2018-03-05",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2025-03-05 ~ 2028-03-04"
    }
  ],
  "company_name": "주식회사 나노백스",
  "corp_no": "285011-*******",
  "financials": {
    "2022": {
      "capital_stock": 282339000,
      "cost_of_sales": 2623070000,
      "current_assets": 1861865000,
      "current_liabilities": 1613710000,
      "gross_profit": 667629000,
      "net_income": 133136000,
      "net_income_bs": 131670000,
      "non_current_assets": 2128334000,
      "non_current_liabilities": 1422000000,
      "non_operating_expenses": 99739000,
      "non_operating_income": 24401000,
      "operating_profit": 208474000,
      "revenue": 3290699000,
      "sga_expenses": 459155000,
      "total_assets": 3990199000,
      "total_equity": 954489000,
      "total_liabilities": 3035710000
    },
    "2023": {
      "capital_stock": 644340000,
      "cost_of_sales": 809410000,
      "current_assets": 1055835000,
      "current_liabilities": 2008766000,
      "gross_profit": 400925000,
      "net_income": -223674000,
      "net_income_bs": -225033000,
      "non_current_assets": 3030436000,
      "non_current_liabilities": 1350000000,
      "non_operating_expenses": 128457000,
      "non_operating_income": 8685000,
      "operating_profit": -103902000,
      "revenue": 1210335000,
      "sga_expenses": 504827000,
      "total_assets": 4086271000,
      "total_equity": 727505000,
      "total_liabilities": 3358766000
    },
    "2024": {
      "capital_stock": 787402000,
      "cost_of_sales": 241078000,
      "current_assets": 1673898000,
      "current_liabilities": 1612955000,
      "gross_profit": 198106000,
      "net_income": -1008881000,
      "net_income_bs": -1008881000,
      "non_current_assets": 3020528000,
      "non_current_liabilities": 1365317000,
      "non_operating_expenses": 117834000,
      "non_operating_income": 4624000,
      "operating_profit": -895671000,
      "revenue": 439184000,
      "sga_expenses": 1093777000,
      "total_assets": 4694426000,
      "total_equity": 1716154000,
      "total_liabilities": 2978272000
    }
  },
  "industry": "동물용 의약품 제조업",
  "investment": [
    {
      "amount": "1,000,003,380",
      "changes": "1,000,003,380",
      "date": "2024-05-24"
    },
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2019-07-09"
    }
  ],
  "main_products": "동물백신 및 분자진단키트개발",
  "phone": "031-572-****",
  "years": [
    2024,
    2023,
    2022
  ]
}